Transgene Starts Two New China Ventures

Transgene announced two new China-related initiatives: with three European institutions, Transgene formed a scientific cooperation program that includes Fudan University Shanghai Cancer Center; it also established a Shanghai subsidiary with a staff of five to perform academic and early-stage projects. Transgene, a French biopharma, positioned the moves as a way of taking advantage of China’s impressive research activity as well as the country’s market for pharmaceuticals. More details.... Stock Symbol: (Euronext: TNG) Share this with colleagues: var switchTo5x=true; stLight.options({publisher:'d7871f5b-67bc-4d30-b66f-1465d0b97213'});  
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.